Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05128890

Evaluation of Resection Techniques for Pancreatic Tumors

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint.

The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Surgery Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Liver Diseases Liver Neoplasms Liver Tumor Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Pancreas Tumor Pancreatic Diseases Pancreatic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

Location status: Recruiting

About this study

The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until December 2020. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
  • Patients 18 years old or older

Exclusion criteria

  • Patients that have not undergone pancreatic resection surgeries
  • Patients under 18 years of age

Treatment and study plan

Resection techniques for pancreatic and liver tumors

Procedure

to compare open versus minimally invasive pancreatic resection techniques and analyze the different outcome variables from the clinical standpoint

Other names: minimally invasive pancreatic resection techniques

Primary outcomes

  1. Patient Survival

    Time frame: through study completion, an average of 1 year

    It will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.

  2. Length of stay

    Time frame: Up to 1 year

    It will be calculated in days. The days stayed in hospital post-procedure.

  3. Complication rates

    Time frame: through study completion, an average of 1 year

    Patient may visit physician or hospital for any symptoms or may need hospitalizations.

  4. Operative time

    Time frame: up to 10 hours

    The time required for the procedure.

  5. Transfusion rate

    Time frame: through study completion, an average of 1 year

    If any post-procedure transfusion required, will be recorded.

  6. 30 and 90 day readmission rate

    Time frame: through study completion, an average of 1 year

    After the procedure any hospital admissions up to 30 days will be recorded.

  7. Hospital charges

    Time frame: through study completion, an average of 1 year

    The hospital charges for the procedure will be recorded.

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Methodist Health System

Other

Registry information

Important dates

Study start
2016
Primary completion
2027
Study completion
2027
First posted
Nov 22, 2021
Registry last updated
Mar 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.